Bio-Techne [TECH] vs Praxis Precision [PRAX] Detailed Stock Comparison

Bio-Techne Corporation

NASDAQ
Loading...

Praxis Precision Medicines Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Bio-Techne Corporation wins in 12 metrics, Praxis Precision Medicines Inc. wins in 2 metrics, with 0 ties. Bio-Techne Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bio-Techne Corporation Praxis Precision Medicines Inc. Better
P/E Ratio (TTM) 117.16 N/A N/A
Price-to-Book Ratio 4.55 9.46 Bio-Techne Corporation
Debt-to-Equity Ratio 20.07 0.01 Praxis Precision Medicines Inc.
PEG Ratio -0.82 -38.31 Bio-Techne Corporation
EV/EBITDA 28.87 -26.32 Bio-Techne Corporation
Profit Margin (TTM) 6.41% 0.00% Bio-Techne Corporation
Operating Margin (TTM) 14.51% 0.00% Bio-Techne Corporation
EBITDA Margin (TTM) 14.51% N/A N/A
Return on Equity 3.80% -45.83% Bio-Techne Corporation
Return on Assets (TTM) 6.09% -28.69% Bio-Techne Corporation
Free Cash Flow (TTM) $256.55M $-249.12M Bio-Techne Corporation
Dividend Yield 0.62% N/A N/A
1-Year Return 6.89% 501.76% Praxis Precision Medicines Inc.
Price-to-Sales Ratio (TTM) 7.35 N/A N/A
Enterprise Value $9.19B $8.58B Bio-Techne Corporation
EV/Revenue Ratio 7.56 N/A N/A
Gross Profit Margin (TTM) 62.72% N/A N/A
Revenue per Share (TTM) $8 N/A N/A
Earnings per Share (Diluted) $0.49 $-13.48 Bio-Techne Corporation
Beta (Stock Volatility) 1.47 2.97 Bio-Techne Corporation
Short % of Float 5.09% 14.21% Bio-Techne Corporation

Bio-Techne Corporation vs Praxis Precision Medicines Inc. Stock Performance Analysis

Loading Price Chart...

TECH
PRAX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bio-Techne Corporation4.02%6.69%29.72%15.08%-4.29%-5.83%
Praxis Precision Medicines Inc.-0.77%4.46%-22.78%-13.27%-4.29%-7.63%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bio-Techne Corporation6.89%-31.20%-49.99%96.15%179.21%318.28%
Praxis Precision Medicines Inc.501.76%1,560.93%-17.42%-36.07%-36.07%-36.07%

Performance & Financial Health Analysis: Bio-Techne Corporation vs Praxis Precision Medicines Inc.

MetricTECHPRAX
Market Information
Market Cap i$9.07B$9.60B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i2,151,790391,453
90 Day Avg. Volume i2,370,067416,321
Last Close$56.17$264.54
52 Week Range$43.20 - $72.16$37.19 - $366.52
% from 52W High-22.16%-27.82%
All-Time High$135.96 (Sep 20, 2021)$914.27 (Jan 04, 2021)
% from All-Time High-58.69%-71.07%
Growth Metrics
Quarterly Revenue Growth-0.01%N/A
Quarterly Earnings Growth0.14%-1.00%
Financial Health
Profit Margin (TTM) i0.06%0.00%
Operating Margin (TTM) i0.15%0.00%
Return on Equity (TTM) i0.04%-0.46%
Debt to Equity (MRQ) i20.070.01
Cash & Liquidity
Book Value per Share (MRQ)$12.62$34.85
Cash per Share (MRQ)$0.93$21.52
Operating Cash Flow (TTM) i$251.25M$-249,068,000
Levered Free Cash Flow (TTM) i$274.30M$-146,253,744
Dividends
Last 12-Month Dividend Yield i0.62%N/A
Last 12-Month Dividend i$0.40N/A

Valuation & Enterprise Metrics Analysis: Bio-Techne Corporation vs Praxis Precision Medicines Inc.

MetricTECH (Nov 10, 2025)PRAX (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i117.16N/A
Forward P/E i26.21-38.31
PEG Ratio i-0.82-38.31
Price to Sales (TTM) i7.35N/A
Price to Book (MRQ) i4.559.46
Market Capitalization
Market Capitalization i$9.07B$9.60B
Enterprise Value i$9.19B$8.58B
Enterprise Value Metrics
Enterprise to Revenue i7.56N/A
Enterprise to EBITDA i28.87-26.32
Risk & Other Metrics
Beta i1.472.97
Book Value per Share (MRQ) i$12.62$34.85

Financial Statements Comparison: Bio-Techne Corporation vs Praxis Precision Medicines Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTECH (2025)PRAX (2025)
Revenue/Sales i1.22B0
Cost of Goods Sold i429.36MN/A
COGS % of Revenue i35.2%-
Gross Profit i790.27MN/A
Gross Margin i64.8%-
Research & Development i99.50M267.12M
Operating Income (EBIT) i242.80M-326.20M
Operating Margin i19.9%-
EBITDA i357.57M-326.06M
EBITDA Margin i29.3%-
Pre-Tax Income i98.46M-303.27M
Pre-Tax Income % of Revenue i8.1%-
Income Tax i25.06MN/A
Income Tax % of Revenue i2.1%-
Net Income (Profit) i73.40M-303.27M
Profit Margin i6.0%-

Balance Sheet & Liquidity Metrics

MetricTECH (2025)PRAX (2025)
Cash & Equivalents i162.19M357.33M
Total Current Assets i608.30M610.91M
Total Current Assets % of Revenue i49.9%-
Total Current Liabilities i175.85M59.77M
Total Current Liabilities % of Revenue i14.4%-
Long-Term Debt i429.96M0
Long-Term Debt % of Revenue i35.3%-
Total Shareholders Equity i1.92B878.14M
Retained Earnings i1.07B-1.14B
Retained Earnings % of Revenue i87.4%-
Property, Plant & Equipment i73.40M415,000

Cash Flow Statement Comparison

MetricTECH (2025)PRAX (2025)
Operating Cash Flow i185.64M-257.32M
Operating Cash Flow % of Revenue i15.2%-
Capital Expenditures i-31.01M-56,000
Free Cash Flow i256.55M-249.12M
FCF Margin i21.0%-
Debt Repayment i-77.00MN/A
Common Stock Repurchase i-275.73MN/A

Short Interest & Institutional Ownership Analysis

MetricTECHPRAX
Shares Short i6.94M3.95M
Short Ratio i2.599.07
Short % of Float i5.09%14.21%
Shares Outstanding i154.97M25.20M
Float Shares i153.94M25.78M
% Held by Insiders i0.28%0.40%
% Held by Institutions i102.89%106.12%
% Held by Public i-3.17%-6.52%

Dividend Analysis & Yield Comparison: Bio-Techne Corporation vs Praxis Precision Medicines Inc.

MetricTECHPRAX
Last 12-Month Dividend i$0.40N/A
Last 12-Month Dividend Yield i0.62%N/A
3-Year Avg Annual Dividend i$0.32N/A
3-Year Avg Dividend Yield i0.12%N/A
3-Year Total Dividends i$0.96N/A
Ex-Dividend DateFeb 13, 2026N/A